Topic
Cannabis hyperemesis syndrome
💡 What You Need to Know
- Definition: Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by recurrent episodes of severe nausea, intractable vomiting, and abdominal pain in chronic, heavy cannabis users.
- Key Feature: Patients often find temporary relief from symptoms by taking hot showers or baths.
- Causation: Directly linked to long-term, frequent use of cannabis and cannabinoid products.
- Resolution: Complete and sustained cessation of all cannabis use is the only definitive cure for CHS.
🤒 Associated Symptoms
- Prodromal Phase: Early morning nausea, abdominal discomfort, fear of vomiting, and generalized malaise.
- Hyperemetic Phase: Intense, cyclical nausea and vomiting that can last for hours or days, severe diffuse abdominal pain, dehydration, and significant weight loss.
- Compulsive Hot Bathing: A hallmark symptom where individuals seek prolonged hot showers or baths for temporary symptom relief.
- Electrolyte Imbalance: Due to persistent vomiting, patients are at high risk for hypokalemia, hyponatremia, and metabolic alkalosis.
🛡 Crucial Precautions
- Cannabis Cessation: Advise immediate and complete discontinuation of all cannabis and cannabinoid products to prevent recurrence and progression of symptoms.
- Hydration Management: Monitor closely for signs of dehydration and electrolyte disturbances, initiating intravenous fluid replacement as needed.
- Avoid Triggers: Educate patients that continued cannabis use, even in small amounts, will perpetuate the syndrome and negate treatment efforts.
- Differential Diagnosis: Ensure other causes of cyclical vomiting (e.g., cyclic vomiting syndrome, gastroparesis, Addison's disease) are considered and ruled out.
🍽 Dietary Directions & Restrictions
- Acute Phase: Maintain NPO (nothing by mouth) status during severe emesis to prevent aspiration and allow the gastrointestinal tract to rest.
- Fluid Reintroduction: Once vomiting subsides, gradually introduce small sips of clear liquids, oral rehydration solutions, or ice chips.
- Bland Diet Progression: Advance to a bland, low-fat diet (e.g., toast, crackers, rice, bananas) in small, frequent portions as tolerated.
- Absolute Restriction: Strictly avoid all forms of cannabis, including edibles, oils, and synthetic cannabinoids, as re-exposure will trigger symptoms.
⚠️ Attendant Guidelines
- Emergency Care: Seek immediate medical attention for severe dehydration, intractable vomiting, altered mental status, or signs of electrolyte imbalance.
- Symptomatic Relief: While antiemetics are often ineffective, consider benzodiazepines (e.g., lorazepam) for anxiety and agitation, and topical capsaicin cream for abdominal pain relief.
- Withdrawal Management: Be prepared to manage potential cannabis withdrawal symptoms (e.g., irritability, insomnia, anxiety) upon cessation.
- Psychological Support: Refer patients to substance use counseling and support groups to aid in long-term cannabis abstinence.
🩺 Physician's Perspective
- Clinical Diagnosis: CHS is primarily a clinical diagnosis based on a history of chronic cannabis use, cyclical vomiting, and resolution of symptoms with cannabis cessation.
- Treatment Focus: The cornerstone of treatment is complete cannabis abstinence, supported by aggressive symptomatic management during acute episodes.
- Patient Education: Emphasize the direct link between cannabis use and symptoms to foster patient understanding and compliance with cessation.
- Long-term Management: Address underlying substance use disorder with appropriate referrals and follow-up to prevent relapse.
🎓 Academic & Nursing Corner
- Comprehensive Assessment: Obtain a detailed history of cannabis use (frequency, quantity, duration, type) and associated symptoms, including hot bathing habits.
- Fluid & Electrolyte Monitoring: Closely monitor vital signs, intake/output, and laboratory results for signs of dehydration and electrolyte derangements.
- Symptom Management: Administer prescribed antiemetics, IV fluids, and pain relief, noting the effectiveness of interventions.
- Patient Education & Support: Educate patients on CHS, the importance of abstinence, and provide resources for addiction support and relapse prevention.
🔬 Clinical Reference Index
- Pathophysiology: Proposed mechanisms involve dysregulation of the endocannabinoid system, particularly cannabinoid receptor type 1 (CB1) and transient receptor potential vanilloid 1 (TRPV1) receptors, affecting gastrointestinal motility and thermoregulation.
- Pharmacological Interventions: Antiemetics (e.g., ondansetron, metoclopramide) often have limited efficacy. Haloperidol and benzodiazepines have shown promise in refractory cases.
- Diagnostic Criteria: While no universally accepted criteria exist, key features include chronic cannabis use, cyclical vomiting, abdominal pain, and resolution with abstinence.
- Epidemiology: Incidence is increasing, particularly in regions with cannabis legalization, due to increased potency and accessibility of cannabinoid products.